Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial

BACKGROUND: Bronchiectasis guidelines recommend antibiotics for the treatment of acute respiratory exacerbations, but randomised placebo-controlled trials in children are lacking. We hypothesised that oral amoxicillin–clavulanate and azithromycin would each be superior to placebo in achieving sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Vikas, Grimwood, Keith, Ware, Robert S, Byrnes, Catherine A, Morris, Peter S, Masters, I Brent, McCallum, Gabrielle B, Binks, Michael J, Smith-Vaughan, Heidi, O'Grady, Kerry-Ann F, Champion, Anita, Buntain, Helen M, Schultz, André, Chatfield, Mark, Torzillo, Paul J, Chang, Anne B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172658/
https://www.ncbi.nlm.nih.gov/pubmed/31427252
http://dx.doi.org/10.1016/S2213-2600(19)30254-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172658/
https://www.ncbi.nlm.nih.gov/pubmed/31427252
http://dx.doi.org/10.1016/S2213-2600(19)30254-1

Ejemplares similares